Brief: Xeris Biopharma Q2 Net Income USD -15.005 Million
Aug 08 (Reuters) - Xeris Biopharma Q2 basic EPS USD -0.1. * Q2 operating income USD -8.187 million * Q2 product revenue USD 46.512 million vs. IBES estimate USD 45.8 million
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest